218 results
Presentation for NITAGs and Programme managers on the evidence for single dose HPV vaccine schedules
Ces recommandations sur l’utilisation des vaccins anti-PVH ont été émises par le Groupe stratégique consultatif d’experts sur la vaccination (SAGE) de l’OMS lors de sa réunion d’avril...
Maldives_Joint Covid-19 cPIE and HPV PIE,Maldives_Joint Covid-19 cPIE and HPV PIE
Workshop presentation
Allows access to up-to-date and comprehensive information on Gavi-supported vaccines (including Rotavirus, PCV, HPV and TCV). Provides an overview of WHO prequalified products for the vaccine groups...
COSTVAC is an Excel-based toolkit that provides structured guidance on how to estimate the cost of routine immunization from a sample of health facilities and administrative levels of the health...
The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each...
UNIVAC is a single universal vaccine impact and cost-effectiveness decision support model with a standardized, accessible Excel-based (now based in R), interface and a familiar set of input steps and...
The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a...
The Single-dose HPV Vaccine Evaluation Consortium collates and synthesizes existing evidence and evaluates new data on the potential for single-dose HPV vaccination. Their goal is to inform global...
Peu d’interventions visent les jeunes adolescents et celles qui existent ne parviennent pas toujours à les atteindre. Cela est dû au fait que les adolescents ont généralement peu de contacts...
Le Consortium d’évaluation des vaccins à dose unique contre le PVH a été formé pour rassembler et synthétiser les données existantes et pour évaluer celles plus récentes sur le potentiel...
Ce document résume une revue et une évaluation complètes des données actuelles publiées sur le schéma de vaccination anti-PVH à dose unique, effectuées par les chercheurs du Consortium...
This video was developed by the Immunization Academy for use both in and outside of Tanzania.
Advocacy, communication and social mobilization communication plan for HPV vaccine introduction in Tanzania
Tanzania rolling advocacy, communication, and social mobilization strategy. (DRAFT)
Communication materials developed for cohort 1 and cohort 2. Also available in Shona and Ndebele.
Communication materials developed for cohort 1 and cohort 2. Also available in Shona and Ndebele.
Communication materials developed for cohort 1 and cohort 2. Shona and Ndebele versions also available.
Tanzania HPV vaccine community and school register
Tanzania Routine Immunization health facility register including HPV vaccine
Daily summary sheet used for multi- age cohort 1 (2018 campaign) in Zimbabwe
Tanzania's Roll Out Plan identifies responsible EPI person and technical partner, deliverables, and timeline for main HPV vaccine introduction activities.
HPV vaccine and IPV introduction training were combined as they were being introduced simultaneously.
HPV vaccine introduction training and microplanning slides. HPV vaccine and IPV introduction training were combined as they were being introduced simultaneously. The slide decks included are those...
Training agenda used in Kwekwe district as part of HPV vaccine introduction.
Senegal HPV vaccine introduction Plan
Questionnaires used for readiness assessment prior to national HPV vaccine introduction in Zimbabwe.
The Single-dose HPV Vaccine Evaluation Consortium collates and synthesizes existing evidence and evaluates new data on the potential for single-dose HPV vaccination. Their goal is to inform global...
This brief summarizes a comprehensive review and assessment of current, published evidence for a single-dose HPV vaccination schedule. The review was undertaken by researchers in the Single-Dose HPV...
A synthesis of the full review on current, published evidence relevant to single-dose HPV vaccination. This includes immunogenicity, efficacy and effectiveness; identification of gaps in the...
This study provides the most up-to-date understanding of current and future global trends and drivers of HPV supply and demand. It also identifies actions to help address the current and expected...
The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that...
There are few interventions targeting young adolescents and those that do exist are often not adequately reaching them. This is because the number of contacts between the health system and...
Toolkit to develop girl centered materials for communication around HPV vaccination
The human papillomavirus (HPV) vaccination school-based programme for girls aged 12–13 years began in Ireland in 2010. Initially, the proportion of students who completed the vaccination course was...
Guide for health managers and service providers on HPV vaccination in the context of a (3 doe schedule ) demonstration programme in Zambia
Guidelines for the health works involved in the HPV vaccination in the Zambian demonstration programme (Note: 3 dose schedule)
Guide pour la vaccination du vaccine anti-VPH lors du programme de demonstration au Cameroun
Consent form for start of school year for parents to consent to screening and HPV& TT vaccination
Comprehensive website from the Ireland HSE with all materails fact sheets and communication materials for the HPV programme
Pratcical introduction guide with FAQ for Health workers and programme managers
As of November 2018, nine countries are in a state of accelerated transition from Gavi support to self-financing1, and 16 countries have transitioned out of Gavi support2. These countries have...
Several countries across regions and income groups have notified WHO of constraints to their access of HPV vaccines. The issue of affordability has also been raised, particularly by non-Gavi MICs....
The HPV Vaccine Introduction Clearing House is a unique space to find WHO publications, tools and other important resources on the human papillomavirus vaccine.
The purpose is to help guide HPV...
This report is a companion to the World Health Organization’s (WHO) 2016 guide for Introducing HPV Vaccine Into National Immunization Programmes. It primarily summarizes country-reported...
PRIME Tool is an Excel-based modelling tool for assessing the economic and human impact of vaccination against human papillomavirus.
Key messages and FAQ on HPV vaccination and cervical cancer prevention for teachers
Guide pour (la formation pour ) les enseignants impliqués dans la vaccination HPV
Fiche pour enregister les cibles et la couverture des filles scolarisées
Tool to identify the age of girls between 9 and 14 years of age based on their birthday
Leaflet on HPV vaccination with key messages for parents and girls
Registry and weekly clinic updates for HPV vaccination. ministry of health South Africa
HPV vaccination information leaflet for girls and parents, 2 dose schedule,. NHS England
Guide for facilitators to carry out HPV vaccination training
Technical guidelines for the introduction of HPV vaccine
Vaccination with Human Papillomavirus (HPV) vaccine is recommended for 11–12 years-old, but uptake is suboptimal. Current messaging focuses on HPV infection transmission and prevention. Parents...
Article shows how introduction with Cervarix vaccine in Scotland led to strong reductions in HPV infection and CIN 2+ lesions in vaccinated women 10 years after start of introduction
Three highly effective vaccines are available to prevent human papillomavirus (HPV) infection, and they have been introduced in many countries around the world. This article describes advances and...
Objective: The objective was to investigate how state level strategies in South Carolina could maximize HPV vaccine uptake. Design: An environmental scan identified barriers, facilitators, and...
BACKGROUND: Vaccines should be stored and handled according to manufacturer specifications. Inadequate cold chain management can affect potency; but, limited data exist on adverse events (AE)...
Highlights
•High HPV vaccination coverage is critical for preventing cervical cancer worldwide.
•School-based programs effectively deliver vaccines to adolescents attending school.
•We...
Background: On Sept 1, 2008, Scotland launched routine vaccination for human papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92·4% were fully vaccinated in...
Recommendations on the use of HPV vaccines were issued by the WHO Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting in April 2022, and subsequently endorsed by WHO.
This...
Background: HPV vaccination uptake in boys is suboptimal in many jurisdictions, particularly in the absence of publicly funded HPV vaccination programs. Parents represent key decision-makers of HPV...
Vaccination reminders must both inform and persuade, and text messages designed for this purpose must do so in 160 characters or less. We tested a strategy for improving the impact of HPV vaccination...
Despite the strong scientific and medical consensus around usefulness and safety of vaccines, a proportion of people remain concerned and unsure about vaccines and/or immunization programs....
In South Africa, HPV vaccination programme has been incorporated recently in the school health system. Since doctors are the most trusted people regarding health issues in general, their knowledge...